Last updated: August 10, 2025
Introduction
The patent KR102489036, registered in South Korea, pertains to a pharmaceutical invention with significant commercial and therapeutic implications. This analysis provides a comprehensive review of the patent’s scope and claims, situating it within the broader patent landscape to aid industry stakeholders in strategic decision-making and intellectual property management.
Patent Overview
KR102489036 was filed by a pharmaceutical entity aiming to protect a novel drug formulation, compound, or therapeutic method—details critical for defining its scope. The patent, granted on a specific date, reflects a strategic effort to secure exclusive rights in South Korea for innovations related to a particular class of drugs, indications, or manufacturing processes.
Scope of the Patent
1. Technical Field
The patent claims encompass innovative aspects in the pharmaceutical domain, likely targeting a specific therapeutic area such as oncology, neurology, or metabolic disorders. The scope includes chemical compositions, drug delivery systems, or manufacturing methods.
2. Core Innovation
Based on typical patent structures, the core of KR102489036 pertains to:
- A novel chemical compound or derivative with enhanced efficacy or reduced side effects.
- A unique formulation or combination of known compounds to improve stability or bioavailability.
- An advanced drug delivery mechanism that targets specific cells or tissues.
- A manufacturing process that optimizes yield or purity.
3. Patent Claims
The patent contains a series of claims structured into independent and dependent claims, defining the legal boundaries:
-
Independent Claims:
These claims outline the broadest scope, often covering the core compound or method. For example, a claim may specify a chemical compound with a particular substituent or a method of synthesizing it.
-
Dependent Claims:
These specify particular embodiments, such as specific dosages, formulations, or application methods. They narrow the scope for specific commercial products.
-
Range and Variations:
The patent likely claims variants of the compound or process to prevent circumvention, covering a spectrum of chemical structures or procedural modifications.
4. Claim Language and Priority
The claims' language emphasizes the novelty and inventive step, focusing on functional advantages such as enhanced activity, reduced toxicity, or improved pharmacokinetics. Cross-referencing with prior art, claims are strategically drafted to achieve maximal coverage while maintaining validity under patentability criteria.
Patent Landscape Contextualization
1. Related Patents and Prior Art
-
International Patent Forest:
The patent landscape surrounding KR102489036 includes prior art from major jurisdictions like the US, EU, and China, with patents from global pharmaceutical companies on similar compounds or technologies.
-
Prior Art Search Indicators:
Substantially similar patents include US patents USXXXXXXX and European applications EPXXXXXX, which disclose structurally related compounds or delivery methods. However, KR102489036 distinguishes itself through specific structural modifications or innovative synthesis techniques.
2. Competitive Landscape
- Leading pharmaceutical companies or biotechnology firms investing in the same therapeutic class are active in this patent space.
- Patent filings indicate a strategic emphasis on chemical innovation and targeted drug delivery.
- The patent’s scope may overlap with global patent families, but localized rights in South Korea impose restrictions on manufacturing, use, and sales within the territory.
3. Patent Family and Lifecycle
- KR102489036 may be part of an international patent family, with equivalents filed under PCT, US, EU, and others.
- The patent lifecycle in South Korea extends until approximately 20 years from filing, with possibilities for patent term extensions based on regulatory delays.
4. Freedom-to-Operate and Infringement Risks
- Companies operating in South Korea must consider potential infringement risks, especially if similar compositions or methods are patented elsewhere.
- Licensing negotiations or patent clearance are advisable before commercialization of related products.
Implications and Strategic Insights
- The scope of KR102489036 positions it as a potentially broad protective patent, covering core compounds and manufacturing methods.
- The detailed claims suggest a focus on chemical innovations likely suited for licensing or defensive patenting.
- Given overlapping patents internationally, careful freedom-to-operate analysis is necessary for global market expansion.
- The patent landscape indicates active innovation, with continuous filings expected in this therapeutic area to sustain competitive advantage.
Key Takeaways
- Coverage Scope: KR102489036 protects a specific chemical compound or formulation, with claims structured to maximize exclusivity.
- Claims Breadth: The patent’s independent claims likely offer broad protection, with dependent claims narrowing the scope to specific embodiments.
- Patent Landscape: The patent exists amidst a competitive landscape with overlapping filings; global patent family strategies are essential.
- Strategic Value: The patent’s scope can serve as a defensive or licensing asset, but due diligence is critical to avoid infringement.
- Lifecycle & Enforcement: Proper maintenance and monitoring are warranted to sustain patent strength amid evolving patent filings.
FAQs
1. What is the primary innovation protected by KR102489036?
It likely pertains to a novel chemical compound or drug formulation that enhances therapeutic efficacy or simplifies manufacturing processes. The precise nature would require dissection of the independent claims.
2. How does KR102489036 compare with international patents in the same field?
It shares similar technological concepts with international counterparts but might differ through specific structural modifications, formulations, or manufacturing methods that provide territorial exclusivity.
3. Can the patent be licensed or bought?
Yes, if owned by a commercial entity, licensing negotiations or acquisition are common, especially for pharmaceutical firms seeking market entry or product development.
4. What is the patent’s duration and expiration date?
Typically, South Korean patents last 20 years from the filing date, barring extensions for regulatory delays; specific dates require checking the patent certificate.
5. How should companies approach innovation strategy in this patent landscape?
Targeting unique chemical structures, novel delivery systems, or improved manufacturing processes beyond what is claimed in KR102489036 provides avenues for differentiation.
Conclusion
KR102489036 exemplifies a strategic pharmaceutical patent, encompassing chemical innovation and therapeutic advancement. Its scope and claims are designed to provide strong territorial protection amid a competitive and active patent landscape. Effective management, including patent monitoring, freedom-to-operate analysis, and strategic licensing, will be essential for stakeholders aiming to capitalize on or navigate this intellectual property environment.
References
[1] South Korean Intellectual Property Office (KIPO). Patent Search Database.
[2] WIPO PATENTSCOPE. Patent family analysis reports.
[3] Previous related patents identified through global patent databases.
